# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Eva Perón (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML025-SYN-TD
- Date: 1951-02-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucía Barragán, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- She has bled after intercourse and between periods for months and is exhausted, and she wants to know the cause **S**
- Whatever the results show, she wants to be told the truth herself, in Spanish, before anyone else is told **S**
- She wants to keep working and to understand how any treatment would affect her body and her chance of having children **S**

## Your goals

- Diagnosis and stage explained to her directly, in Spanish, with time for questions, before any treatment decision. Target: 1951-03-02. Recorded outcome: Diagnosis given to her in person at the second visit and the stage at the third; she made the treatment and fertility decisions herself. **S**
- Hemoglobin 10 g/dL or more before radiation begins. Target: 1951-03-02. Recorded outcome: Hemoglobin 10.2 g/dL. **S**
- Chemoradiation and brachytherapy completed within eight weeks. Target: 1951-05-18. Recorded outcome: Completed in eight weeks, with five cisplatin doses. **S**
- No evidence of disease on PET-CT and examination three months after treatment. Target: 1951-08-17. Recorded outcome: Complete metabolic response; examination without tumor. **S**
- PHQ-9 below 5 by six months. Target: 1951-08-17. Recorded outcome: PHQ-9 4. **S**

## What we agreed to do

- Diagnosis of a visible cervical lesion: punch biopsy at this visit, an HPV test and cytology, a pregnancy test, a blood count and ferritin; a lesion that looks like cancer is biopsied directly rather than managed by the screening algorithm. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors (2019) **S**
- Urgent gynecologic oncology consultation, on the day the biopsy result is given: diagnosis, staging, treatment by stage, and fertility and ovarian function counseling. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018) **S**
- Truthful disclosure as she asked: the biopsy result given to her in person, in Spanish, at a visit with time set aside, before anyone else is told; she chooses who is present and who is told; a professional medical interpreter for clinicians who do not speak Spanish, never a family member; information shared step by step, checking what she wants to know. Guideline: Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017) **S**
- Iron deficiency anemia: ferrous sulfate daily, a blood count at about one month, a ferritin at the end of the course, and acetaminophen rather than anti-inflammatory painkillers for pelvic pain. Guideline: CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026) **S**
- FIGO 1943 staging: pelvic MRI and FDG PET-CT, kidney function before cisplatin, an HIV test, and an examination of the vagina and parametria. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)) **S**
- Fertility and ovarian function counseling before treatment: chemoradiation ends the ability to carry a pregnancy and usually ends ovarian function; egg or embryo freezing (about two weeks), surgical moving of the ovaries out of the radiation field, and a gestational carrier were explained; her decision is recorded. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update (2018) **S**
- Psychosocial support: the oncology social worker, the PHQ-9 and GAD-7 at diagnosis, before treatment, at the end of treatment and in follow-up, spiritual care when she asks, and help planning work around treatment. Guideline: Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) **S**
- Definitive chemoradiation for stage IIB disease: pelvic external beam radiation 45 Gy in 25 fractions with weekly cisplatin 40 mg/m2, then image-guided high-dose-rate brachytherapy, all within eight weeks; weekly blood count, creatinine and magnesium; ondansetron for nausea and loperamide for diarrhea. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Revised FIGO staging for carcinoma of the cervix uteri (2018 (published 2019)) **S**
- Survivorship care: a vaginal dilator three times a week, estradiol with progesterone for radiation-induced menopause until the usual age of menopause, gynecologic oncology review every three months for two years, PET-CT about three months after treatment, and warning symptoms to report. Guideline: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027) **S**

## Follow-up

- 1951-02-09: New patient with four months of bleeding after intercourse and between periods and tiredness: history in Spanish, speculum examination, a visible cervical mass biopsied, HPV test and cytology, anemia tests, and her wishes about how results are given **S**
- 1951-02-17: Biopsy result given to her in person, and gynecologic oncology consultation the same day: diagnosis, staging plan, treatment options, and fertility and ovarian function counseling **S**
- 1951-03-02: Staging results (pelvic MRI and PET-CT), FIGO stage, and her treatment and fertility decisions before chemoradiation **S**
- 1951-05-18: Review two weeks after completing chemoradiation and brachytherapy: side effects, menopause symptoms, and survivorship care **S**
- 1951-08-17: Review three months after treatment: PET-CT response, examination, anemia, mood, and the follow-up plan **S**
- 1951-09-21: Periodic adult preventive visit after cancer treatment **S**

This teaching document does not replace care from a qualified clinician.
